Yajima Toshitaka相关文献与解析，生知库 | 链接生命科学的每一步

Nakamaru, Ryo; Shiraishi, Yasuyuki; Kohno, Takashi; Nagatomo, Yuji; Akiyama, Hiroki; Motoya, Yuki; Fukui, Masato; Yajima, Toshitaka; Yoshikawa, Tsutomu; Kohsaka, Shun

心力衰竭

心血管

发表日期：2024

文献求助收藏

Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome

钠-葡萄糖协同转运蛋白2抑制剂从降血糖药物发展成为治疗心肾代谢综合征的关键药物

期刊:Frontiers in Endocrinology

影响因子:4.6

doi:10.3389/fendo.2023.1111984

Akiyama, Hiroki; Nishimura, Akihiro; Morita, Naru; Yajima, Toshitaka

Correction: Kohsaka et al. Risk-Benefit Balance of Renin-Angiotensin-Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia. J. Clin. Med. 2022, 11, 5828

更正：Kohsaka 等人，《高钾血症心力衰竭患者停用肾素-血管紧张素-醛固酮抑制剂的风险获益平衡》，《临床医学杂志》，2022 年，11，5828。

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm12072578

Kohsaka, Shun; Okami, Suguru; Morita, Naru; Yajima, Toshitaka

Health Care Cost Analysis of PPI or P-CAB-First Treatment in Patients With Gastroesophageal Reflux Disease

胃食管反流病患者首选PPI或P-CAB治疗的医疗保健成本分析

期刊:Journal of Clinical Gastroenterology

影响因子:2.7

doi:10.1097/MCG.0000000000001685

Miwa, Hiroto; Shiotani, Akiko; Takeda, Masayoshi; Eda, Masahiro; Kato, Toshiaki; Yajima, Toshitaka

胃食管反流病

发表日期：2023

文献求助收藏

Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia

高钾血症发作后RAASi治疗不足的临床影响

期刊:BMC Nephrology

影响因子:2.4

doi:10.1186/s12882-022-03054-5

Kanda, Eiichiro; Rastogi, Anjay; Murohara, Toyoaki; Lesén, Eva; Agiro, Abiy; Arnold, Matthew; Chen, Gengshi; Yajima, Toshitaka; Järbrink, Krister; Pollack, Charles V Jr

发表日期：2023

文献求助收藏

Impact of treatment of hyperkalaemia on quality of life: design of a prospective observational cohort study of long-term management of hyperkalaemia in patients with chronic kidney disease or chronic heart failure in Japan

高钾血症治疗对生活质量的影响：一项前瞻性观察队列研究的设计，该研究旨在探讨日本慢性肾脏病或慢性心力衰竭患者高钾血症的长期管理情况。

期刊:BMJ Open

影响因子:2.3

doi:10.1136/bmjopen-2023-074090

Shibagaki, Yugo; Yamazaki, Hajime; Wakita, Takafumi; Ware, John E; Wang, Jui; Onishi, Yoshihiro; Yajima, Toshitaka; Sada, Ken-Ei; Yamamoto, Yosuke; Fukuhara, Shunichi

Validation of a new instrument for measuring disease-specific quality of life: A pilot study among patients with chronic kidney disease and hyperkalemia

验证一种用于测量疾病特异性生活质量的新工具：一项针对慢性肾脏病合并高钾血症患者的试点研究

期刊:

影响因子:

doi:10.37737/ace.23003

Fukuhara, Shunichi; Yamazaki, Hajime; Wakita, Takafumi; Ware, John E Jr; Wang, Jui; Onishi, Yoshihiro; Yajima, Toshitaka; Sada, Kenei; Yamamoto, Yosuke; Shibagaki, Yugo

发表日期：2023

文献求助收藏

Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries

2型糖尿病患者新发心血管和肾脏疾病相关的医疗保健利用成本：一项涵盖12个国家的多国观察性研究

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.14698

Norhammar, Anna; Bodegard, Johan; Eriksson, Jan W; Haller, Hermann; Linssen, Gerard C M; Banerjee, Amitava; Karasik, Avraham; Mamouris, Pavlos; Tangri, Navdeep; Taveira-Gomes, Tiago; Maggioni, Aldo P; Botana, Manuel; Thuresson, Marcus; Okami, Suguru; Yajima, Toshitaka; Kadowaki, Takashi; Birkeland, Kåre I

Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment

2型糖尿病患者开始二线治疗后3年内治疗满意度的变化

期刊:Journal of Clinical Endocrinology & Metabolism

影响因子:5.1

doi:10.1210/clinem/dgac420

Mita, Tomoya; Katakami, Naoto; Takahara, Mitsuyoshi; Kawashima, Masaru; Wada, Fumitaka; Akiyama, Hiroki; Morita, Naru; Kidani, Yoko; Yajima, Toshitaka; Shimomura, Iichiro; Watada, Hirotaka

Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients

用于预测早期2型糖尿病患者心力衰竭和慢性肾脏病发展的机器学习模型

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-022-24562-2

Kanda, Eiichiro; Suzuki, Atsushi; Makino, Masaki; Tsubota, Hiroo; Kanemata, Satomi; Shirakawa, Koichi; Yajima, Toshitaka

Treatment patterns and trajectories in patients after acute heart failure hospitalization

急性心力衰竭住院患者的治疗模式和轨迹

Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome

钠-葡萄糖协同转运蛋白2抑制剂从降血糖药物发展成为治疗心肾代谢综合征的关键药物

Correction: Kohsaka et al. Risk-Benefit Balance of Renin-Angiotensin-Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia. J. Clin. Med. 2022, 11, 5828

更正：Kohsaka 等人，《高钾血症心力衰竭患者停用肾素-血管紧张素-醛固酮抑制剂的风险获益平衡》，《临床医学杂志》，2022 年，11，5828。

Health Care Cost Analysis of PPI or P-CAB-First Treatment in Patients With Gastroesophageal Reflux Disease

胃食管反流病患者首选PPI或P-CAB治疗的医疗保健成本分析

Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia

高钾血症发作后RAASi治疗不足的临床影响

Impact of treatment of hyperkalaemia on quality of life: design of a prospective observational cohort study of long-term management of hyperkalaemia in patients with chronic kidney disease or chronic heart failure in Japan

高钾血症治疗对生活质量的影响：一项前瞻性观察队列研究的设计，该研究旨在探讨日本慢性肾脏病或慢性心力衰竭患者高钾血症的长期管理情况。

Validation of a new instrument for measuring disease-specific quality of life: A pilot study among patients with chronic kidney disease and hyperkalemia

验证一种用于测量疾病特异性生活质量的新工具：一项针对慢性肾脏病合并高钾血症患者的试点研究

Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries

2型糖尿病患者新发心血管和肾脏疾病相关的医疗保健利用成本：一项涵盖12个国家的多国观察性研究

Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment

2型糖尿病患者开始二线治疗后3年内治疗满意度的变化

Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients

用于预测早期2型糖尿病患者心力衰竭和慢性肾脏病发展的机器学习模型